Advanced Glycation End Products, Inflammation, and Chronic Metabolic Diseases: Links in a Chain?

REFERENCES

• Ames, J. M. (2007). Evidence against dietary advanced glycation endproducts being a risk to human health. Mol. Nutr. Food Res. 51(9):1085–1090.
   PubMed Web of Science ®Google Scholar
• Ames, J. (2008). Determination of N-(Carboxymethyl) lysine in foods and related systems. New York Acad. Sci. 1126:20–24.
   PubMed Web of Science ®Google Scholar
• Assar, S. H., Moloney, C., et al. (2009). Determination of N (carboxymethyl) lysine in food systems by ultra performance liquid chromatography-mass spectrometry. Amino Acids. 36:317–326.
   PubMed Web of Science ®Google Scholar
• Barlovic, D. P., Soro-Paavonen, A., et al. (2011). RAGE biology, atherosclerosis and diabetes. Clin. Sci. 121:43–55.
   PubMed Web of Science ®Google Scholar
• Birlouez-Aragon, I., Saavedra, G., et.al. (2010). A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. Am. J. Clin. Nutr. 91(5):1220–1226.
   PubMed Web of Science ®Google Scholar
• Birlouez-Aragon, I., Pischetsrieder, M., et al. (2004). Assessment of protein glycation markers in infant formulas. Food Chem. 87:253–259.
   Web of Science ®Google Scholar
• Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature. 414:813–820.
   PubMed Web of Science ®Google Scholar
• Cai, W., He, J-C., et al. (2008). Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. Am J Pathol. 173(2):327–336.
   PubMed Web of Science ®Google Scholar
• Cai, W., Gao, Q-d., et al. (2002). Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction. Mol. Med. 8(7):337–346.
   PubMed Web of Science ®Google Scholar
• Chang, J. B., Chu, N. F., Su, J. T., Hsieh, A. T., Hung, Y. R. (2011). Advanced glycation end products in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patients. Lipids Health Dis. 10:228.
   PubMed Web of Science ®Google Scholar
• Coughlan, M. T., Yap, F. Y. T., et al. (2011). Advanced glycation end products are direct modulators of beta cell function. Diabetes. 60(10):2523–2532.
   PubMed Web of Science ®Google Scholar
• Delgado-Andrade, C., Rufian-Henares, J. A., et al. (2006). Study on fluorescence of Maillard reaction components in breakfast cereals. Mol Nutr Food Res. 50:799–804.
   PubMed Web of Science ®Google Scholar
• Delgado-Andrade, C., Seiquer, I., et al. (2007). Maillard reaction indicators in diets usually consumed by the adolescent population. Mol Nutr Food Res. 51:341–351.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis, E., Piouka, A., et al. (2009). Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovarian syndrome. Eur J Endocrinol. 160:847–853.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis, E., Piperi, C., et al. (2005). Increased levels of serum advanced glycation end-products in women with polycystic ovarian syndrome. Clin Endocrinol. 62:37–43.
   PubMed Web of Science ®Google Scholar
• Drusch, S., Faist, V., et al. (1999). Determination of N-carboxymethyllysine in milk products by a modified reversed phase HPLC method. Food Chem. 65:547–553.
   Web of Science ®Google Scholar
• Friedja, M. L., Tarhouni, K. (2012). The AGE-Breaker ALT-711 restores high blood flow-dependent remodeling in mesenteric resistance arteries in a rat model of type 2 diabetes. Diabetes. 61:1562–1572.
   PubMed Web of Science ®Google Scholar
• Fritz, G. (2011). RAGE: a single receptor fits multiple ligands. Cell Press: Trends Biochem. Sci. 36(12):625–632.
   PubMed Web of Science ®Google Scholar
• Goldberg, T., Weijing, C., et al. (2004). Advanced glycoxidation end products in commonly consumed foods. JADA. 104:1287–1291.
   Web of Science ®Google Scholar
• Gugliucci, A., Kotani, K., et al. (2009). Short term low calorie diet intervention reduces serum advanced glycation end products in healthy overweight or obese adults. Ann Nutr Metab. 54:197–201.
   PubMed Web of Science ®Google Scholar
• Harcourt, B., Sourris, K. C., et al. (2011). Targeted reduction of advanced glycation improves renal function in obesity. Kidney Int. 80:190–198.
   PubMed Web of Science ®Google Scholar
• Hull, G. L., Woodside, J. V., et al. (2012). N-carboyxmethyl lysine content of foods commonly consumed in a Western-style diet. Food Chem. 131:170–174.
   Web of Science ®Google Scholar
• Kalousova, M., Zima, T., et al. (2005). Advanced glycooxidation end products in chronic disease—clinical chemistry and genetic background. Mutation Res. 579:37–46.
   PubMed Web of Science ®Google Scholar
• Kilhovd, B. K., Juutilainen, A., et al. (2005). High serum levels of advanced glycation end products predict increased coronary heart disease mortality in non-diabetic women but not in non-diabetic men: a population-based 18 year follow-up study. Arterioscler Thromb Vasc Biol. 25:815–820.
   PubMed Web of Science ®Google Scholar
• Kilhovd, B. K., Berg, T. J., et al. (1999). Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care. 22:1543–1548.
   PubMed Web of Science ®Google Scholar
• Kilhovd, B. K., Juutilainen, A., et al. (2007). Increased serum levels of advanced glycation end products predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study. Diabetologia. 50:1409–1417.
   PubMed Web of Science ®Google Scholar
• Kiuchi, K., Nejima, J., et al. (2001). Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients. Heart. 83:1.
   Google Scholar
• Koyama, H., Shoji, T., et al. (2005). Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol. 25:2587–2593.
   PubMed Web of Science ®Google Scholar
• Koschinsky, T., He, C-J., et al. (1997). Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc. Natl. Acad. Sci. 94:6474–6479.
   PubMed Web of Science ®Google Scholar
• Li, Y. M., Steffes, M., et al. (1996) Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. Proc. Natl. Acad. Sci. U S A. 93:3902–07.
   PubMed Web of Science ®Google Scholar
• Lopes-Virella, M. F., Hunt, K. J., Baker, N. L., Lachin, J., Nathan, D. M., Virella, G. (2011). Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima media thickness and its progression in type 1 diabetes. Diabetes. 60(2):482–589.
   Web of Science ®Google Scholar
• Mittelmaier, S., Pischetsrieder, M. (2011). Multistep ultrahigh performance liquid chromatography/tandem mass spectrometry analysis for untargeted quantification of glycating activity and identification of most relevant glycation products. Anal. Chem. 83:9660–9668.
   PubMed Web of Science ®Google Scholar
• Negrean, M., Stirban, et al. (2007). Effects of low and high advanced glycation endproduct meals on macro and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am. J. Clin. Nutr. 85:1236–1243.
   PubMed Web of Science ®Google Scholar
• Nin, J. W., Jorsal, A., et al. (2011). Increased serum concenetration of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients. Heart. 85:87–91.
   Google Scholar
• Norata, G. D., Garlaschelli, K., et al. (2009). Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population. Nutr. Metab. Cardiovasc. Dis. 19:129–134.
   PubMed Web of Science ®Google Scholar
• Piroddi, M., Palazzetti, I., et al. (2011). Circulating levels and dietary intake of the advanced glycation end product marker CML in chronic kidney disease patients on a conservative predialysis therapy: a pilot study. J. Renal. Nutr. 21(4):329–339.
   PubMed Web of Science ®Google Scholar
• Ramasamy, R., Yan, S., Schmidt, A. M. (2010). Advanced glycation endproducts: from precursors to RAGE: round and round we go. Amino Acids. 1–10.
   Google Scholar
• Ramasamy, R., Vannucci, S. J., et al. (2005). Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration and inflammation. Glycobiology. 15(7):16R–28R.
   PubMed Web of Science ®Google Scholar
• Requena, J. R., Ahmed, M. U., et al. (1997). Carboxyethylethanolamine, a biomarker of phospholipids modification during the Maillard reaction in vivo. J. Biol. Chem. 272:17453–17479.
   Web of Science ®Google Scholar
• Rosen, E. D., Spiegelman, B. (2006). Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 444:847–853.
   PubMed Web of Science ®Google Scholar
• Saudek, C. D., Derr, R. L., et al. (2006). Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA. 295(14):1688–1697.
   PubMed Web of Science ®Google Scholar
• Schmidt, A. M., Vianna, M., et al. (1992). Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chem. 267(21):14987–14997.
   PubMed Web of Science ®Google Scholar
• Schwedler, S. B., Metzger, T., et al. (2002). Advanced glycation endproducts and mortality in hemodialysis patients. Kidney Int. 62:301–310.
   PubMed Web of Science ®Google Scholar
• Sebekova, K., Somoza, V., et al. (2009). Plasma advanced glycation end products are decreased in obese children compared with lean controls. Int. J. Ped. Obesity. 4:112–118.
   PubMed Web of Science ®Google Scholar
• Sell, D. R., Monnier, V. M. (2012). Molecular basis of arterial stiffening: role of glycation—a mini review. Gerontology. 58:227–237.
   PubMed Web of Science ®Google Scholar
• Semba, R. D., Arab, L., et al. (2011). Fat mass is inversely associated with serum carboxymethyl-lysine, and advanced glycation end product, in adults. J Nutrition. 141:1726–1730.
   PubMed Web of Science ®Google Scholar
• Semba, R. D., Bandinelli, S., et al. (2010). Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study. Eur. J. Appl. Physiol. 108:109–115.
   Web of Science ®Google Scholar
• Semba, R. D., Nicklett, E. J., et al. (2010). Does accumulation of advanced glycation end products contribute to the aging phenotype? J. Gerontology. 65A(9):963–975.
   Google Scholar
• Semba, R. D., Fink, F. C., et al. (2010). Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore Longitudinal Study of Aging. J. Renal. Nutrition. 20(2):74–81.
   PubMed Web of Science ®Google Scholar
• Semba, R. D., Fink, J. C., et al. (2009). Carboxymethyl-lysine, an advanced glycation end product, and decline of renal function in older community-dwelling adults. Eur. J. Nutr. 48:38–44.
   PubMed Web of Science ®Google Scholar
• Sgarbieri, V. C., Amaya, J. (1973). J. Nutr. 103:657–663.
   PubMed Web of Science ®Google Scholar
• Somoza, V., Wenzel, E., et al. (2006). Dose-dependent utilization of casein-linked lysinoalanine, N(epsilon)-fructoselysine and N(epsilon)-carboxymethyllysine in rats. Mol. Nutr. Food Res. 50:833–841.
   PubMed Web of Science ®Google Scholar
• Srey, C., Haughey, S. A., et al. (2010). Immunochemical and mass spectrometric analysis of Nϵ-(Carboxymethyl)lysine content of AGE-BSA systems prepared with and without selected antiglycation agents. J. Agric. Food Chem. 58:11955–11961.
   PubMed Web of Science ®Google Scholar
• Standards of Medical Care in Diabetes. (2012). Diabetes Care. 35(S1):S11–S63.
   PubMedGoogle Scholar
• Stirban, A., Negrean, M., et al. (2008). Dietary advanced glycation endproducts and oxidative stress. Ann. NY. Acad. Sci. 1126:276–279.
   PubMed Web of Science ®Google Scholar
• Stirban, A., Negrean, M., et al. (2006). Prevents macro and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care. 29:2064–2071.
   PubMed Web of Science ®Google Scholar
• Tan, D., Wang, Y., et al. (2008). Methylglyoxal: its presence in beverages and potential scavengers. New York Acad. Sci. 1126:72–75.
   PubMed Web of Science ®Google Scholar
• Tan, K. C. B., Bucala, R., et al. (2004). Association between acute-phase reactants and advanced glycation end products in type 2 diabetes. Diabetes Care. 27:223–228.
   PubMed Web of Science ®Google Scholar
• Tan, K. C. B., Chow W-S, et al. (2002). Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care. 25:1055–1010.
   PubMed Web of Science ®Google Scholar
• Tessier, F. J., Birlouez-Aragon, I. (2012). Health effects of dietary Maillard reaction products: the results of ICARE and other studies. Amino Acids. 42:1119–1131.
   PubMed Web of Science ®Google Scholar
• Trivelli, L. A., Tanney, H. M., et al. (1971). Hemoglobin components in patients with diabetes mellitus. N Engl. J. Med. 284:353–357.
   PubMed Web of Science ®Google Scholar
• Uchiki, T., Weikel, K., et al. (2011). Glycation-altered proteolysis as a pathologic mechanism that links dietary glycemic index, aging, and age-related disease (in non-diabetics). Aging Cell. 1:13.
   Google Scholar
• Ueno, H., Koyama, H., et al. (2010). Receptor for advanced glycation end produces regulation of adiposity and adiponectin is associated with atherogenesis in apo-E deficient mouse. Atherosclerosis. 211:431–436.
   PubMed Web of Science ®Google Scholar
• Uribarri, J., Woodruff, S., et al. (2010). Advanced glycation end products in foods and a practical guide to their reduction in the diet. J. Am. Diet Assoc. 110:911–916.
   PubMed Web of Science ®Google Scholar
• Uribarri, J., Negrean, M., et al. (2007). Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and non diabetic subjects. Diabetes Care. 30:2579–2582.
   PubMed Web of Science ®Google Scholar
• Uribarri, J., Cai, W., et al. (2007). Circulating glycotoxins and dietary advanced glycation end-products: two links to inflammatory response, oxidative stress, and gaining. J. Gerontol. A Biol. Sci. Med. Sci. 62:427–433.
   PubMed Web of Science ®Google Scholar
• Uribarri, J., Tuttle, K. R. (2006). Advanced glycation end products and nephrotoxicity of high protein diets. Clin. J. Am. Soc. Nephrol. 1:1293–1299.
   PubMed Web of Science ®Google Scholar
• Uribarri, J., Cai, W., et al. (2005). Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Ann. NY. Acad. Sci.1043:461–466.
   PubMed Web of Science ®Google Scholar
• Vlassara, H., Uribarri, J., et al. (2009). Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management or prevention of reduced renal function in elderly persons. Semin Nephrol. 29:594–603.
   PubMed Web of Science ®Google Scholar
• Vlassara, H., Uribarri, J., et al. (2008). Advanced glycation end product homeostasis: exogenous oxidants and innate defenses. Ann. NY. Acad. Sci. 1126:46–52.
   PubMed Web of Science ®Google Scholar
• Vlassara, H., Palace, M. R. (2002). Diabetes and advanced glycation endproducts. J. Int. Med. 251:87–101.
   PubMed Web of Science ®Google Scholar
• Wu, C. H., Huang, S. M., et al. (2011). Inhibition of advanced glycation endproduct formation by foodstuffs. Food Funct. 2:224–234.
   PubMed Web of Science ®Google Scholar
• Yaacoub, R., Saliba, R., et al. (2008). Formation of lipid oxidation and isomerization products during processing of nuts and sesame seeds. J. Agric. Food Chem. 56:7082–7090.
   PubMed Web of Science ®Google Scholar
• Yamagishi, S., Adachi, H., et al. (2006). Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in non diabetic subjects. Metabolism. 55:1227–1231.
   PubMed Web of Science ®Google Scholar